Cellink targets lab-on-a-chip applications with Nanoscribe acquisition - IDEX Health & ScienceIDEX Health & Science

    Disclaimer:

    The views, information, or opinions expressed in the Industry News RSS feed belong solely to the author and do not necessarily represent those of IDEX Health & Science and its employees.

    Cellink targets lab-on-a-chip applications with Nanoscribe acquisition

    Article obtained from Optics.org RSS Feed.

    Swedish bio-printing pioneer says it will gain a ‘leg up’ on competition with cash-plus-stock deal worth up to €50M.

    READ MORE
    May, 25 2021 |

    IDEX Health & Science is the global authority in fluidics and optics, bringing to life advanced optofluidic technologies with our products, people, and engineering expertise. Intelligent solutions for life.